From Risk to Resilience: Healthcare Providers and the Psychedelic Therapy Revolution
Treatment
Currently, MDMA-assisted therapy for PTSD and psilocybin for depression disorders await approval from the FDA. Meanwhile, practitioners are creating spaces to give their patients this revolutionary experience.
The importance of serious, scientific screening is paramount in selecting participants and providing for their well being. A thorough questionnaire is of the essence.
Thank you for the honest perspective. Much appreciated!
In researching my first (future) psychedelic therapy center experience, I am naturally less than comfortable with the idea of an enterprise that may have an overriding incentive to sign up paying customers – regardless of whether the therapy is appropriate for the individual.
Articles like this help greatly in my exploration
Excellent! Opens up a new understanding for after care that can easily be overlooked in the excitement to press on without understanding.
Agreed!
I’m really glad to hear this information helped Cristobal. It’s so important to be transparent about psychedelic therapy nuances.